Palobiofarma has been selected as one of the 99 most innovative companies in the European Innovation Council Accelerator. As a result, this company based in Navarra, with the support of Sodena, has received approval for the European project that finances phase II of the PBF-680 product in EPOC and granted financial support amounting to EUR 2.5 million. In addition, it has been offered the possibility of partial funding for phase III of this product through a capital investment of an additional EUR 15 million in the form of a capital increase.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.